WEBINAR: Development of Potential Cell Therapy for Parkinson’s Disease
Join IPN on Tuesday, October 27 at 2:00 PM EST for a presentation from Benjamin Hoehn, Vice President of Clinical Development at BlueRock Therapeutics. Dr. Hoehn will discuss the development of potential cell therapy approaches for Parkinson’s disease, including bemdaneprocel, which is currently being studied in a Phase 3 clinical trial for Parkinson’s disease. REGISTER […]